29/07/2016 22:40:29 Cookie Policy +44 (0) 207 0700 961 Free Membership Login
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +21.00p +0.42% 5,048.00p 5,045.00p 5,048.00p 5,114.00p 4,918.00p 5,000.00p 4,592,799 16:30:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16,768.9 2,082.9 151.3 29.8 63,800.85

Astrazeneca (AZN) Latest News (2)

More Astrazeneca News
Astrazeneca Takeover Rumours

Astrazeneca (AZN) Share Charts

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Intraday Astrazeneca Chart

Intraday Astrazeneca Chart

Astrazeneca (AZN) Discussions and Chat

Astrazeneca (AZN) Top Chat Posts

DateSubject
29/7/2016
09:20
Astrazeneca Daily Update: Astrazeneca is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 5,027p.
Astrazeneca has a 4 week average price of 4,576.90p and a 12 week average price of 4,173.10p.
The 1 year high share price is 5,114p while the 1 year low share price is currently 3,680p.
There are currently 1,263,883,777 shares in issue and the average daily traded volume is 3,460,328 shares. The market capitalisation of Astrazeneca is £63,800,853,062.96.
30/6/2016
18:41
nisbet: Monty, you really don't understand what is happening. AstraZeneca has seen a boost to its earnings in sterling equivalent to the diminution of sterling's value relative to the U.S. dollar. Consequently, a relative re-rating is taking place. In addition, (an added bonus) the Astra dividend is paid in U.S. Dollars so its yield is buttressed to a level which provokes a relative adjustment. This happens by way of a rising share price. In summation, your observations and views can best be described as naive and lacking in erudition.
19/5/2016
15:29
kevdav0: Oh help what is happening to our share price. Something is causing this
12/5/2016
11:34
philanderer: ‘Hold’ AstraZeneca for ‘cutting-edge’ drugs pipeline Shore Capital has resumed coverage of pharmaceutical giant AstraZeneca (AZN) as the company undergoes a period of transition. Shore Capital analyst Tara Raveendran initiated coverage of the UK drugs company with a ‘hold’ but did not set a share price target. ‘AstraZeneca is undergoing a period of transition,’ she said. ‘Its mature franchises are slowing in the face of competition and genericisation, however, it boasts a full but emerging pipeline of unique assets in existing and new therapeutic areas that are not yet contributing to the top-line. ‘While we are more positive over the medium to longer term, encouraged by management’s commitment to cutting-edge science and its exciting pipeline, lacklustre earnings and limited pipeline visibility are likely to be near-term overhangs for the stock,’ she added. This week the company borrowed €2.2 billion in a private loan note placing on which it will pay a fixed coupons of 0.25%, 0.75% and 1.25%. Yesterday the shares added 8.5p or 0.2% to £39.36. HTTP://citywire.co.uk/money/the-expert-view-william-hill-aa-and-astrazeneca/a907553?re=40070&ea=290170&utm_source=BulkEmail_Money_Daily&utm_medium=BulkEmail_Money_Daily&utm_campaign=BulkEmail_Money_Daily#i=4
06/5/2016
11:30
kdconn: What a bad day . Looks like share price will hit £37 or worse still below . Is there any way back .
04/5/2016
16:56
kevdav0: Why has the market reacted so badly to TAKEDA RESPIRATORY takeover. Share price is heading towards £37 which is just awful.
29/4/2016
13:14
montyhedge: Good conference call on the future, everything on track.Share price could have a run big time now. With Astra a sitting duck for Pfizer.
26/4/2016
17:14
kevdav0: Is it because of the boards forthcoming results that is sending share price down . Sorry I'm new to this
31/3/2016
23:29
philanderer: AstraZeneca is walking a fine line as setbacks put doubt on 2017 target IC VIEW: Chief executive Pascal Soriot forecast a return to sales growth by 2017, but as that deadline creeps closer setbacks like these have made us more sceptical of the group's ability to achieve this target. Investors too are starting to bow out, with the share price falling 15 per cent so far this year. But for now we're keeping our faith in the long-term strategy, but with so much hanging in the balance we’ll be keeping our eyes peeled. Hold. Last IC view: Hold, 4,217p, 5 Feb 2016 article: HTTP://www.investorschronicle.co.uk/2016/03/31/comment/chronic-investor-blog/astrazeneca-is-walking-a-fine-line-as-setbacks-put-doubt-on-target-EDl2RGz7PDB3fBZruATUfM/article.html
16/2/2016
06:15
indianspan: http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-38-1-Potential-Upside-Indicated-by-Deutsche-Bank-21856171/ AstraZeneca plc with EPIC/TICKER had its stock rating noted as Retains with the recommendation being set at BUY this morning by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 5700 GBX on its stock. This now indicates the analyst believes there is a possible upside of 38.1% from the opening price of 4128.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 82 points and decreased 171.5 points respectively. AstraZeneca plc has a 50 day moving average of 4,407.83 GBX and a 200 day moving average of 4,329.91 GBX. The 52 week high share price is 4931.68 GBX while the 52 week low is 3746 GBX. There are currently 1,261,546,027 shares in issue with the average daily volume traded being 3,095,152. Market capitalisation for is 51,994,619,5ase (CKD), diabetes mellitus (DM) and chronic heart failure (CHF). All rights reserved (c) 2016 The Jerusalem Post Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers Envoyer par mail 03 GBP.
02/5/2014
08:43
harvester: Share price below indicative offer since not all cash offer and risk of pfizer share price weakening as well as risk of the deal failing . AZN share price closed last night at 4851 up 151 based on suspicious after hours trades . At normal market close the share price was 4676.5 . Big money at stake. Hence bound to be some insider trading going on .

Astrazeneca (AZN) Latest Trade

Astrazeneca Most Recent Trade

Trade Type Trade Size Trade Price Trade Date Trade Time Currency
261 5,047.89 29 Jul 2016 17:08:33 GBX
Astrazeneca share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20160729 21:40:30